In an interview with CURE, Dr. Susana Campos, clinical director of the Division of Gynecologic Oncology and assistant professor of medicine at Harvard Medical School, discussed re ...

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) highlighted progress across its clinical pipeline and reaffirmed its financial outlook during its 2026 Virtual Investor Day, outlining plans to advance its ...

Health insurance loss, changes "may undermine continuity of critical treatment," researche ...

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

March 02, 2026 - PRESSADVANTAGE - PureLee Redefined, a medical spa in Colorado Springs, has introduced Exomind mental ...

Fort Myers, Florida - March 04, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

Many changes regarding Delaware's Ryan White HIV/AIDS Program are slated to take effect April 1. Here's what you need to know ...

The Trump administration explored giving the green light to a potential treatment for a broad swath of people on the autism spectrum — but a new drug approval scales back those ...

A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher.

The notion that we can assume people suffering from substance use disorders will freely choose what is best for them and their children is regularly undermined by reality. Too many children have paid ...

Reforms would increase security screenings and safety checks, better monitor surveillance cameras and improve access to drug ...